Atrial Fibrillation Patients Are at Increased Risk of Dementia, Regardless of Anticoagulation Use, New Study Finds

Atrial fibrillation patients are at higher risk of developing all forms of dementia compared to patients without atrial fibrillation, according to new study.

“We are initiating a series of new studies that are aimed to understand what treatments may reduce the risk of developing dementia in atrial fibrillation patients.”

— Jared Bunch, MD, Intermountain Medical Center Heart Institute.

SALT LAKE CITY , UT, USA , November 29, 2016 /EINPresswire.com/ — Atrial fibrillation patients who use the drug warfarin to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

Atrial fibrillation is an abnormal heart rhythm that raises the risk of small clots forming in the heart and leading to a stroke. Warfarin is the most common anticoagulant drug used worldwide to lower risk of the harmful clots from forming and causing stroke.

For the study, Intermountain researchers looked at more than 6,000 patients who had no history of dementia and were chronically anticoagulated using warfarin for any indication – not just atrial fibrillation. The patients were then divided into two groups: Those with atrial fibrillation who were using warfarin, and those using warfarin who did not have atrial fibrillation.

After adjusting for multiple variations, patients with atrial fibrillation were two to three times more likely to develop dementia compared to the patients who were on warfarin, but did not have a diagnosis of atrial fibrillation.

“Atrial fibrillation patients are at higher risk of developing all forms of dementia compared to patients without atrial fibrillation. Warfarin is used to lower risk of stroke in patients with atrial fibrillation, but when the blood levels of the drug are erratic it contributes to the dementia risk. This dementia risk is observed in people with and without atrial fibrillation that are exposed to long-term warfarin treatment” said Jared Bunch, MD, lead author of the study and director of electrophysiology at the Intermountain Medical Center Heart Institute in Salt Lake City.

“Even when we consider the influence of warfarin on dementia risk, the presence of atrial fibrillation conveys additional risk of dementia. This suggests that they way we manage the abnormal heart rhythm, beyond just the practice of preventing blood clots through warfarin, may be a way we can further lower the risk of all forms of dementia, including Alzheimers disease, in patients with atrial fibrillation,” Dr. Bunch added.

Results of the study were presented during the American Heart Association's 2016 Scientific Sessions in New Orleans on Nov. 15.

Seven years ago, researchers from the Intermountain Medical Center Heart Institute found that patients with atrial fibrillation had much higher rates of all forms of dementia, including Alzheimer’s disease. Since then, researchers have continued to explore the association between atrial fibrillation and dementia in an effort to better understand and identify ways to prevent dementia in heart patients.

“Further research is needed to identify the many complex mechanisms that link atrial fibrillation to dementia,” said Dr. Bunch. “We are initiating a series of new studies that are aimed to understand what treatments may reduce the risk of developing dementia in atrial fibrillation patients.”

Other members of the Intermountain Medical Center Heart Institute team include Kevin Graves, BS; Heidi T. May, PhD; Tami L. Bair, RN; Victoria Jacobs, PhD; Brian G. Crandall, MD; Michael Cutler, MD; Jeffrey S. Osborn, MD; Charles Mallender, MD; John D. Day, MD; and Peter Weiss, MD.

Intermountain Medical Center is the flagship facility for the Intermountain Healthcare system, which is based in Salt Lake City.

Jess Gomez
Intermountain Medical Center
801-507-7455
email us here

Atrial Fibrillation Research from AHA 2016 Scientific Sessions


Source: EIN Presswire

Hospital Capacity Management Solutions Market to Grow at 5% CAGR through 2025

North America will continue to be the largest market for hospital capacity management solutions globally.

VALLEY COTTAGE, NEW YORK, UNITED STATES, November 29, 2016 /EINPresswire.com/ — Future Market Insights, in its latest report titled, “Hospital Capacity Management Solutions Market: Global Industry Analysis and Opportunity Assessment, 2015-2025”, has projected the global hospital capacity management solutions market revenue to expand at a CAGR of 5.0% during the forecast period (2015-2025).

Hospital capacity management solutions (HCMS) enable better and timely care of patients and consequently reduces length of patient stay in hospital. Hospital capacity management solutions track clinical data of patients, alerts doctor, nurse or caregiver nearest to patient in need, in order to ensure timely care so that patients can be discharged earlier. Hospital capacity management solutions analyze and predict bed occupancy at the emergency department (ED) of hospitals, thereby reduce wait time by 35-50%.

Global hospital capacity management solutions market has been estimated to account for US$ 800.0 Mn by 2015 end, mainly owing to rising patient pool resulting in rising demand for hospital capacity management solutions.

Request Free Report Sample with TOC@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1013

The report offers global hospital capacity management solutions market analysis in terms of market value (US$ Mn) by application, product type, region and delivery mode, and provides information regarding market trends, regulatory affairs, competitive landscape, market estimations and forecast. Usage of hospital capacity management solutions among big hospitals has increased significantly due to technological advancements and benefits these solutions offer in managing large patient pool. Real-time locating system is widely preferred by big hospitals. Increasing patient pool globally is a major factor expected to boost overall demand for hospital capacity management solutions over the forecast period.

North America market has been estimated to contribute maximum revenue to the global hospital capacity management solutions market by 2015, and this is expected to increase by 1.6x over the forecast period. In addition, hospital capacity management solutions providers are expected to launch various new and innovative solutions as per demand of hospitals over the forecast period. Western Europe is the next most promising market for hospital capacity management solutions providers. The market value in this region is expected to register a CAGR of 5.5% during the forecast period. High cost of some HCMS, along with late delivery of results and variability in bed demand are factors expected to restrain market growth in the future.

Browse Full Report@ http://www.futuremarketinsights.com/reports/hospital-capacity-management-solutions-market

On the basis of product type, the market is segmented into workflow management solution, asset management solution, bed management solution, quality patient care solution, real time locating system and event driven solution. Among product types, real-time locating system segment is expected to contribute maximum value to the global hospital capacity management solutions market, followed by workflow management solution and bed management solution segments. Increasing incidence of accidents, disease and surgeries is expected to generate more number of patients, which in turn is expected to boost overall demand for hospital capacity management solutions.

On the basis of application, hospital capacity management solutions market is segmented into standalone solutions and integrated solutions. Integrated solutions segment has been estimated to dominate the overall hospital capacity management solutions market by 2015 end, and is expected to register a healthy growth rate over the forecast period. Increasing adoption of hospital capacity management solutions among hospitals for multi–module purpose is fuelling growth of the integrated solutions segment.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1013

On the basis of delivery mode, global hospital capacity management solutions market has been segmented into on-premise solutions and cloud-based solutions. Cloud-based segment is expected to register fastest CAGR in terms of revenue over the forecast period. Cloud-based segment currently accounts for maximum revenue share of the global hospital capacity management solutions market.

Key market participants included in the report are Awarepoint Corporation, Allscripts Healthcare Solutions, Inc., Care Logistics, LLC, McKesson Corporation, Central Logic, STANLEY Healthcare, Sonitor Technologies, Inc., TeleTracking Technologies, Inc., Cerner Corporation and Epic Systems Corporation.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

Abhishek Budholiya
Future Market Insights
+1-347-918-3531
email us here


Source: EIN Presswire

The Future of Parallel Trade: EU Falsified Medicine Directive, Legal Issues, Parallel Distribution, Regional Focus…



Parallel Trade for Pharma

With Brexit and the new EU FMD, what does the future hold for parallel trade? Over 90 leaders in parallel trade will meet in London to discuss upcoming trends

Parallel Trade for Pharma, organised by the SMi Group, will be returning to London in February 2017, for its 11th year.

— SMi Group

LONDON, UNITED KINGDOM, November 29, 2016 /EINPresswire.com/ — The Falsified Medicines Directive introduces tough directives to improve the protection of public health with new pan-European measures to ensure that medicines are safe and that the trade in medicines is strictly controlled.

Falsified medicines (the term "falsified" is used to distinguish the issue from IP violations, so-called "counterfeits") are a major threat to public health and safety. As falsifications become more sophisticated, the risk that falsified medicines reach patients in the EU increases every year. Falsified medicines represent a serious threat to global health and call for a comprehensive strategy both at European and international level. (Source: European Commission)*

Dr Rick Greville, Director Wales and Director Distribution & Supply, The Association of the British Pharmaceutical Industry, will be speaking on “The European Commission’s Falsified Medicines Directive (FMD) – Recent Update” at SMi Group’s Parallel Trade 2017 conference, taking place in London on the 6th and 7th of February.

Dr. Greville will discuss what progress has been made since February 2016, what the market participants need to know about "product information templates", what are the regulatory requirements for nationally authorised products and much more.

Further information on this presentation and the conference programme is available at www.parallel-trade.com/EIN

Parallel Trade for Pharma conference, organised by the SMi Group, will be returning to London in February 2017, for its 11th year. This meeting will bring 90+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices, short term and long term concerns of pharma manufacturers, regulators and parallel traders.
Other key topics to be discussed during the 2-day conference are: Pharmaceutical anti-counterfeiting – Combating the danger from fake drugs, Regional focus – From Germany to Eurasia, Legal view – Intellectual property, competition and regulatory challenges, The future of parallel trade, New trends and their impact on parallel trade and so much more.
The event programme also features three panel debates on: Shortages; Challenges and opportunities for parallel traders; Technology & new trends; and two exclusive post conference workshops on “Understanding IP and competition law issues in parallel trade” (Hosted by Kathy Osgerby, Associate and Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP) and “Parallel Trade – Management Strategies” (Hosted by Janice Haigh, Practice Leader, Market Access, Quintiles).

For further information please refer to www.parallel-trade.com/EIN

Expert Speakers Line up for 2017 includes: The Association of the British Pharmaceutical Industry (Dr Rick Greville, Director Distribution & Supply), Shire International GmbH (Eric Noehrenberg, Director, Regional Market Access Lead, Latin America), Delfarma (Tomasz Dzitko, President), European Association for Euro-Pharmaceutical Companies (Heinz Kobelt, Director European Affairs), ISPOR (Vladimir Zah, Health Economics Consultant), Abacus Medicine (Flemming Wagner, CEO), IMS Health (Alexey Savin, Principal Russia and CIS), Arnold & Porter (UK) LLP (Kathy Osgerby, Associate, and Karoline Zwierzynska, Associate), Europe Economics (Dermot Glynn, Senior Advisor), European Alliance for Access to Save Medicines (Mike Isles, Executive Director), Research Health (Dr Andrew Stainthorpe, Director Market Access and Managed Entry) and many more.

The complete 2-day event programme is available for complimentary download at www.parallel-trade.com/EIN

Latest confirmed attendees include senior representatives from MHRA, AbbVie Deutschland GmbH & Co. KG, Astellas Pharma, AstraZeneca, Teva UK, Vifor Pharma, Janssen Pharmaceutica NV, Napp Laboratories, Ratiopharm GmbH, Kantar Health, Ferring Pharmaceuticals, LEO Pharma, AstraZeneca Czech Republic, Swedish Orphan Biovitrum AB, Amgen, Novartis Pharmaceuticals, Novartis Turkey, LEO Pharma, Johnson & Johnson, Novo Nordisk Pharma, Daiichi Sankyo Europe GmbH, Sunovion Pharmaceuticals Europe Ltd and many more.

Feedback from past attendees of SMi Group’s Parallel Trade: “Interesting conference, generating a good debate from all sides”, “Great conference! Audience very enthusiastic and actively participating in discussions”, “Very good discussing about pricing issues and competition”, “Overall, a very positive experience!”, “The best Parallel Trade conference of the last 5 years!”.

*Source: European Commission http://ec.europa.eu/health/human-use/falsified_medicines/index_en.htm

11th annual Parallel Trade
6-7 February 2017, Holiday Inn Kensington Forum, London, UK
www.parallel-trade.com/EIN
Sponsorship, Exhibition contact: Alia Malick, +44 (0) 207 827 6168, amalick@smi-online.co.uk
Delegates/Group contact: Fateja Begum, +44 (0) 207 827 6184, fbegum@smi-online.co.uk
Media Contact: jrotar@smi-online.co.uk
______________________________end of press-release______________________
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Julia Rotar
SMi Group Ltd
+44 (0) 207 827 6088
email us here


Source: EIN Presswire

MYANMAR LAB EXPO: Myanmar Medical-Pharma-Lab Expo in Yangon, organized by MiTA during 24-26 Feb 2017

MYANMAR LAB EXPO

MHC MYANMAR 2015: Myanmar Pharma Expo

MHC – 2015 was inaugurated by H.E. Dr. Thein Thein Htay, Dy Minister, Ministry of Health (MOH) Myanmar and Dr. Maung Maung Lay, VP of UMFCCI

MYANMAR LAB EXHIBITION: Myanmar Lab Expo will be co-located with Myanmar Pharma Expo & Myanmar Medical Expo in Yangon; twice a year: 24-26Feb & 23-25June 2017.

These Trade Fairs are the Great Market Platforms to initiate & grow Business in Myanmar; find Distributors & JV-Investment Partners and network.

— www.digitalmarketing.ink

WASHINGTON DC & YANGON, USA & MYANMAR, November 28, 2016 /EINPresswire.com/ — MYANMAR LAB EXPO, MYANMAR MEDICAL EXPO, MYANMAR PHARMA EXPO

Myanmar Lab Expo, Myanmar Medical Expo, Myanmar Pharma Expo & Myanmar Investment Conference (MMHC @ YgTF 2017) will be held during 24-26 February 2017 at Tatmadaw Hall, Yangon, Myanmar.

These events will be held twice in 2017; second time during 23-25 June 2017 at Tatmadaw Hall in Yangon.

“MiTA Myanmar Medical & Healthcare Expo” is organized by MiTA “Myanmar Market Partner” for Myanmar Export-Import and JV-Investment.

These “Trade Fairs organized by MiTA” are the Great Market Platforms to initiate & grow Business in Myanmar. Supported by a PROMISE to help you find Medical Distributors & JV-Investment Partners, network with Myanmar Medical Companies, Myanmar Cosmetics Companies, Cosmetics Importers in Myanmar, Myanmar Pharma Importers, Hospitals, Doctors & Policy Makers; and know “how to do business in Myanmar”.

EU Ambassador, Harvard Business School (HBS) and Singapore International Arbitration Center (SIAC) will also present along with UMFCCI and Myanmar Government Ministry officials during YgTF 2017. MiTA Myanmar Exhibitions and Conferences which were held in 2015 & 2016 were grand success.

MYANMAR LAB EXPO, website: http://myanmar-medical-lab-expo.brand-myanmar.com/

SUPPORTING-ORGANIZATIONS:

– HARVARD BUSINESS SCHOOL
– SIAC-SINGAPORE
– Department for International Trade (UK), Myanmar Office
– A-MCC (Australia-Myanmar Chamber of Commerce)
– Mandalay Region Chamber of Commerce and Industry

BROCHURE-Download:
http://mitamyanmar.com/download/medical-pharma-lab-expo-in-myanmar-mhc-ygtf.pdf

– Price-List,
– MYANMAR CONFERENCE Agenda,
– Expo & Conference Hall-Layout,
– Expo-Booth-Facilities and
– Experience (Recommendation) in last Expo

PRICE till 6 January 2017

USD 3100 per 9 SQM (3mx3m) with standard booth-facilities

USD 500 per Conference Delegate with networking lunch & tea-coffee breaks

EXHIBIT PROFILES

1.1 MYANMAR MEDICAL EXPO
1.11 Medical Equipment & Devices
– Medical Equipment & Devices
– Surgical Equipment
– Dental Equipment
– Hospital & Clinical Equipment
– Diagnostic Equipment
– Infection & Sterilization Equipment
– Orthopedic Equipment, etc. 1.12 Medical Services
– Mobility Aids
– Hospital Management Services
– SOS
– Medical Evacuation Services
– Pharmaceutical Machinery
– Analytical and R & D Services

1.2 MYANMAR PHARMA EXPO
1.21 Pharma & Food Supplement
– Pharmaceutical Products
– Bulk Drugs
– Generics & OTC
– Baby Foods
– Food Supplements
– Veterinary Drugs
– Additives
– Intermediates
– Excipients / Food Additives / Natural Extracts Traditional Medicines / Herbal Products Biotechnology
1.22 Pharma Equipment & Machineries
– Tableting
– Tube Filling
– Labelling
– Preparation Machinery
– Packing Machinery
– Pulverizer
– Liquid Filling Machinery
– Filling and Sealing Machine
– Drying Machinery
– Mixer, Coater
– Granulator

1.3 LABORATORY EXPO
1.31 Laboratory Instruments
– Analytical & Lab Instruments
– Material & Water Testing Instruments
– Environmental Lab Instruments
– Testing & Measuring Instruments
– Diagnostics & Medical Instruments
– Lab Automation, etc. 1.32 Laboratory Products & Consumables
– Educational Lab Products for all levels
– Laboratory Animation and Software
– Biotechnology & Life Sciences
– Laboratory Planning
– Lab Glassware & Plastic-ware
– Environmental Science, etc.

HOW TO JOIN THE CONFERENCE & EXPO IN MYANMAR?

Please email following information so that we can email you available booth-numbers and help you to do the online-registration:

– Your contact address and phone-number
– Your company's Contact person name, position, phone-number and email-address.
– Your full company name and address for invoicing purposes.
– How many exhibition-booths (each booth is 9 SQM) and conference delegate-tickets do you want to book?

Email: thazin@mitaservices.com.sg, mhc1@mita-myanmar.com

Phone: +95 9420 110 451, +95 9420 110 666

Dr. MADHAB PAUL, MANAGING DIRECTOR OF MiTA

www.madhabpaul.com

Dr. Madhab Paul, also speak about Opportunities in Myanmar in several international events. His recent speaking engagement was during "Russia & Asia Business Forum"; more info about the Forum: http://raibf.com/en/home-page/ . Dr. Paul traveled extensively in India, USA, Germany, China, Singapore, Vietnam, Philippine, Thailand and Myanmar, as well as, many other countries which he visited for business / work / pleasure for a short period. He did PhD in Civil (Geo-technical) Engineering and has post-graduate education in Law & Management; also did "Doing Business in Emerging Market" a short course from Harvard Business School (HBS). Please email to: isbc@mitaservices.com.sg if you wish to invite Dr. Madhab Paul to speak at your international conference / private investor's meeting.

ORGANIZER: MiTA

MiTA is Myanmar Market Partner for Export-Import and JV-Investment in Myanmar. MiTA Myanmar @ ISBC is preferred Partner for JV-Investment, Export-Import, Real Estate (www.mitaproperty.com) and Manufacturing since 2011. MiTA Services Pte Ltd (Singapore) is providing consulting for investment and trade in Myanmar since 2009. MiTA's one of the major initiatives now is making "Made-In-Myanmar" brand: www.1pya.com

Since 2014, to help you explore Myanmar Market, MiTA is organizing Myanmar Exhibitions, Myanmar Conferences and B-2-B Business Meetings. These events are the "Great Market Platforms" to initiate & grow Business in Myanmar. Supported by a PROMISE to help you find Distributors and JV-Investment Partners, trade Myanmar Market and get to know how to do business in Myanmar.

Think about "Doing Business in Myanmar" Property-Construction Sector, contact MiTA Myanmar; attend MiTA Myanmar Exhibition and Conference for Brand Promotion and Product Launch!

MiTA: MYANMAR MARKET PARTNER Since 2009

Welcome you all to MYANMAR, the land of new OPPORTUNITIES! www.digitalmarketing.ink

DOING BUSINESS IN MYANMAR: Quick-Links

Advantages in Myanmar: http://advantages-myanmar.com/

Myanmar-Trade-Investment News: http://myanmarbusinessnews.mitamyanmar.com/

Myanmar Trade Fair in Mandalay: http://mandalay-business.expo-mita.com/

Myanmar Investment Commission & MIC-Permit: http://myanmarinvestmentbusiness.com/myanmar-investment-commission-mic-permit-company-registration-dica-directorate-of-investment-and-company-administration/

Company Registration in Myanmar: https://mitaservices.com.sg/services/company-incorporation-in-myanmar/foreign-investment-mic-permit-dica-registration/

IEE-EIA-HIA-SIA-CSR in Myanmar: https://mitaservices.com.sg/services/eia-sia-csr-consulting/

Techno-Commercial Due-Diligence in Myanmar: https://mitaservices.com.sg/services/due-diligence-consulting/

JOBS-Recruitment in Myanmar: http://mitajobs.com/

Myanmar FDA Registration: http://myanmar-fda-registration.mitamyanmar.com/

Property Marketing in Myanmar: http://mitaproperty.com/

Myanmar Oil & Gas Exploration, Charter-Hire Offshore Vessels, Fabrication & Installation: https://mitaservices.com.sg/clients-projects-of-mita/

DIGITAL-MARKETING & GLOBAL-BRANDING: www.digitalmarketing.ink

JETRO JAPAN: Myanmar Trade Fair News

Myanmar Medical Laboratory Expo: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarLab_54254
Myanmar Cosmetics, Beauty, Spa & Wellness Products Expo: https://www.jetro.go.jp/j-messe/tradefair_en/spaCOSMO_53989
Myanmar Healthcare: https://www.jetro.go.jp/j-messe/tradefair_en/MHCMYANMAR_53983
Myanmar Pharmaceutical: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarPharma_53984
Myanmar Sports & Fitness: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarPhysiotherapy_53985

Myanmar Medical-Pharma-LAB Expo @ YgTF 2017, February 24-26:

We invite your participation in case you are interested in "Doing Business in Myanmar" or exploring Medical & Healthcare Market in Myanmar.

MiTA DIGITAL MARKETING INK http://digitalmarketing.ink
MiTA Services Pte Ltd
00959420110451
email us here


Source: EIN Presswire

Saudi Arabia Pharmaceutical Market Poised to Grow Steadily: Report

The Saudi Arabia pharmaceutical market is anticipated to witness steady growth on account of increasing emphasis on healthcare and well-being.

VALLEY COTTAGE, NEW YORK, UNITED STATES, November 28, 2016 /EINPresswire.com/ — The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, the Saudi Arabia pharmaceutical market is anticipated to procure value worth US$ 5,209.5 Mn at a y-o-y growth of 6.0 % over 2015. The mounting demand for branded drug products will continue to incite the growth of the Saudi Arabian pharmaceutical market in 2016.

The demand for pharmaceuticals in Saudi Arabia is expected to register substantial growth owing to the increasing penetration of health insurance companies and the rising incidence rate of non-communicable diseases. Furthermore, the exceptional rise in the per capita income of Saudi Arabia is also expected to foster the demand for branded pharmaceutical drugs. Another key factor driving the growth of the pharmaceutical market in Saudi Arabia is the country’s strategic move to allow 100% FDI in the pharmaceuticals sector. Although, the shortage of profound indigenous research capacity in the pharmaceutical industry and the delayed registration of drug and medicine patents is expected to limit the expansion of the market in 2016 and beyond.

Request Free Report Sample with TOC@ http://www.futuremarketinsights.com/reports/sample/rep-gc-1733

Based on the product type, the pharmaceutical market in Saudi Arabia is expected to witness an upsurge in the prescription-type branded drug products. In terms of market value, the branded drugs are estimated to reach US$ 2,760.8 Mn by 2016-end. The demand for generic drugs is projected to secure steady growth, attributing to the insisting promotion of generic drug adoption by healthcare insurance providers.

On the basis of the diseases, the pharmaceutical drugs used for treatment of cardiovascular diseases will continue exhibiting robust growth in 2016. The demand for cardiovascular medications will continue to surge due to the prominence of circulatory disorders in Saudi Arabia. Additionally, the rising prevalence of disorders related to body sugar levels is expected to make diabetes a rapidly growing disease-based sub-segment in the Saudi Arabia pharmaceutical market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/saudi-arabia-pharmaceutical-market

The pharmaceutical market in Saudi Arabia is also segmented on the basis of distribution channel, where retail pharmacies will continue to account for 80% market share compared to hospital pharmacies. The westernised modernisation of retail pharmacies in Saudi Arabia has led to the availability of a wide range drugs and medicinal products, thereby attaining a considerable growth in the retail pharmacy sub-segment in 2016 and further.

The rising resource potential in Saudi Arabia is projected to positively reform the production environment for pharmaceutical manufacturers. In order to expand the market’s size, structuring alliances with well-established native companies is predicted to be a key strategy for global pharmaceutical leaders. The key players in the Saudi Arabia pharmaceutical market include Novartis AG, SPIMACO, Pfizer Inc., and Glaxosmithkline plc., Jamjoom Pharma, and Tabuk Pharmaceutical Manufacturing Co. among others.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gc-1733

Long-term Outlook: The Saudi Arabia pharmaceutical market is expected to expand at a CAGR of 9.0% over the forecast period 2016-2026. In terms of market value, the pharmaceutical market in Saudi Arabia is estimated to be worth US$ 12,281.4 Mn by the end of forecast period.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

Abhishek Budholiya
Future Market Insights
+13479183531
email us here


Source: EIN Presswire

Pharma Cold Chain Distribution: Big Pharma, MHRA and leading logistics companies to meet in London this December



11th annual Cold Chain Distribution 2016

SMi reports (2016.11.28 London) World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016

The aviation industry has made improvements for cold chain distribution, despite improvements there are still challenges that remain unanswered…

— Frederik Wildtgrube, Head of Global Sales, Finnair

LONDON, UNITED KINGDOM, November 28, 2016 /EINPresswire.com/ — Over the last 24 months, we have witnessed market growth and new logistics hubs established around the globe by forwarders and distributors, in order to service and support a more round-the-clock global network for pharmaceutical product supply. Nonetheless, challenges remain with the increasingly fragile biologics product and tightened GDP regulations.

Just a fortnight remains until the SMi Group opens their doors to host the 11th annual conference on Cold Chain Distribution. This year’s event will bring over 120 attendees from all over the world including senior representatives from big pharma, biotech and service providers with responsibilities in supply chain, cold chain, logistics, distribution, packaging, operations, production, manufacturing, QA and QC from Austria, Belgium, Denmark, Finland, France, Ireland, Israel, Netherlands, Switzerland, United Kingdom and other countries to keep abreast of cold chain distribution developments!

Further information available at www.coldchain-distribution.com/EINPR

Cold Chain Distribution 2016 speaker line up includes key decision makers and leading pharma cold chain experts representing MHRA, Danish Medicines Agency, IATA, NHS Blood & Transplant, Sanofi-Aventis, Johnson & Johnson, GlaxoSmithKline, GSK Biologicals, Teva Pharmaceutical, The Grimsby Institute, World Courier, Finnair Cargo, PCI Pharma Services, Cell and Gene Therapy Catapult, Modalis, Exelsius, Vertex International Ltd and more.

The complete 2-day event programme including all speakers and their topics can be viewed at www.coldchain-distribution.com/EINPR

“The aviation industry has made improvements for cold chain distribution, despite improvements there are still challenges that remain unanswered. It's time to discuss the next trends of cold chain distribution as air cargo." Frederik Wildtgrube, Head of Global Sales, Finnair.

Confirmed attendees include key decision makers from Accord Healthcare, Actelion Pharmaceuticals UK, Al Medicines, Alliance Healthcare, Almac Group, Avery Dennison Materials Europe B.V., BIOTRANS SA, Birmingham Children’s Hospital, Bristol-Myers Squibb, Brussels Airport Company, Business Unit Pharma, Catapult Cell & Gene Therapy, Cell Therapy Catapult, Copenhagen Capacity, Copenhagen Univeristy, Danish Medicines Agency, Day Lewis Plc, DBS Ltd, Eberspaecher, Eli Lilly Italia SpA, Envirotainer, Exelsius, Finnair Cargo, Genzyme Pharmaceuticals, GlaxoSmithKline, GSK Biologicals, GW Pharmaceuticals, IATA, Janssen Pharmaceutica N.V., JB360solutions, Johnson & Johnson, Kings College London, Kyowa Kirin International plc., Lysogene, MHRA, Modalis, MSD, NHS Blood & Transplant, Norgine Ltd, Novartis Business Services, Panalpina, PCI Pharma Services, Pfizer Group, Porton Biopharma, ReNeuron, Roche Pharmaceuticals, Sanofi-Aventis, Seer Pharma, Shionogi Ltd, Shire/Global Logistics Validation, Softbox Systems Ltd, Teva Pharmaceutical, The Doctors Laboratory Ltd, The Grimsby Institute, va-Q-tec AG, Vertex Pharmaceuticals (Europe), Wockhardt UK, World Courier, Yourway Transport and many more!

“We consider SMi’s Cold Chain Distribution conference as the industry-leading event in the UK which has always attracted a good mix and level of speakers and delegates, including both our customers and suppliers, who are all key opinion leaders in their respective fields. It serves as a good platform for us to engage with attendees, share best practices and challenge our theories on the future of temperature controlled distribution. As cold chain distribution is our core business, it’s imperative that we continue to evolve in accordance with the needs of our customers.” David Spillett, Key Account Director, World Courier.

Further information available at www.coldchain-distribution.com/EINPR

Cold Chain Distribution 2016 offers to its attendees a fantastic networking opportunity with the leading experts in the industry at a drinks reception on day one followed by a Gala Dinner (invitation only) hosted by World Courier.
We are proud to be sponsored by the leading service providers including: World Courier (Lead Sponsor), Berlinger & Co. AG, Eberspächer, ELPRO, Emball'iso, Finnair Cargo, NEFTAG, Peli BioThermal, Sensitech, SMO Group, Testo Limited, Topa Thermal, va-Q-tech and Yourway Transport.

11th Annual Cold Chain Distribution Conference and Exhibition
Park Plaza Victoria, London, UK
12th-13th December, 2016
www.coldchain-distribution.com/EINPR
Sponsors/Exhibitors: Contact Alia Malick at +44 (0) 7827 6168, amalick@smi-online.co.uk
Delegates/Groups: Contact Fateja Begum at +44 (0) 20 7827 6184, fbegum@smi-online.co.uk
Media Enquiries: Contact Julia Rotar at jrotar@smi-online.co.uk
—————————————END OF PRESS-RELEASE—————————————————–
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Julia Rotar
SMi Group Ltd
+44 (0) 207 827 6088
email us here


Source: EIN Presswire

Palm Desert, California Dentist Selected to the "America's Best Dentists" 2016 Directory

Rene Yvonne Dell’Acqua, DDS

Dr. Rene Yvonne Dell'Acqua, DDS listed as Top Dentist in Family, Cosmetic, Implant & Sedation Dentistry

Dr. Rene Dell'Acqua Selected as Top Dentist in Family, Cosmetic, Implant & Sedation Dentistry

— TodaysBestDentists.com

PALM DESERT, CALIFORNIA , UNITED STATES, November 10, 2016 /EINPresswire.com/ — Palm Desert, California dentist, Dr. Rene Yvonne Dell'Acqua has been selected to the "America's Best Dentists" registry for 2016. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Dell'Acqua practices Family, Cosmetic, Implant & Sedation Dentistry at 74133 El Paseo in Palm Desert, serving patients in Palm Springs, Indian Wells, La Quinta, Palm Desert, Rancho Mirage and throughout the country.

Services include: Cosmetic Dentistry, Implant Restorations, Aesthetic Veneers, Crowns, Bridges, Teeth Whitening and Tooth-Colored fillings. She also provides Full Mouth Reconstruction, Sedation, Invisalign, Sleep Apnea Appliances, Tissue Grafting, Partial and Full Dentures, Root Canals, and Preventative care.

Dr. Dell'Acqua received her Doctor of Dental Surgery degree (DDS) from University of the Pacific in San Francisco. She has taken numerous continuing education courses over the last 14 years that have placed her in the forefront of Cosmetic and General Dentistry. Dr. Dell'Acqua has treated Fortune 500 CEO's, Academy award winners, models, celebrities and pro-athletes, though her practice and fees are reasonable for anyone.

Dr. Dell'Acqua has appeared in numerous television shows, news broadcasts, radio interviews and magazines due to her exceptional expertise in the dental field. An innovator in Spa Dentistry, Dr. Dell'Acqua has incorporated massage, aromatherapy and sedation to provide the most comforting dental environment possible. Dr. Dell'Acqua is a member of American Dental Association, American Academy of Cosmetic Dentistry, Dental Organization for Conscious Sedation, California Dental Association and American Academy of Facial Esthetics.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Rene Yvonne Dell'Acqua, DDS directly at 760-346-8056 or http://www.TheValleysDentist.com.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
5555555555
email us here


Source: EIN Presswire

MYANMAR BEAUTY: Myanmar Beauty-Cosmetics Expo in Yangon, organized by MiTA during 24-26 Feb 2017

MYANMAR BEAUTY – COSMETICS EXPO: 24-26 Feb & 23-25 June 2017

MYANMAR LAB EXPO

MHC – 2015 was inaugurated by H.E. Dr. Thein Thein Htay, Dy Minister, Ministry of Health (MOH) Myanmar and Dr. Maung Maung Lay, VP of UMFCCI

MYANMAR BEAUTY SHOW: Myanmar Cosmetics Expo will be co-located with Myanmar Pharma Expo & Myanmar Lab Expo in Yangon; twice a year: 24-26Feb & 23-25June 2017.

These Trade Fairs are the Great Market Platforms to initiate & grow Business in Myanmar; find Cosmetics Distributors & JV-Investment Partners, network with Myanmar Cosmetics Companies.

— www.digitalmarketing.ink

WASHINGTON DC & YANGON, USA & MYANMAR, November 28, 2016 /EINPresswire.com/ — MYANMAR BEAUTY SHOW, MYANMAR COSMETICS EXPO, MYANMAR PHARMA EXPO:

Myanmar Beauty Expo, Myanmar Cosmetics Expo, Myanmar Pharma Expo & Myanmar Investment Conference (MHC @ YgTF 2017) will be held during 24-26 February 2017 at Tatmadaw Hall, Yangon, Myanmar.

These events will be held twice in 2017; second time during 23-25 June 2017 at Tatmadaw Hall in Yangon.

“MiTA Myanmar Beauty & Cosmetics Expo” is organized by MiTA “Myanmar Market Partner” for Myanmar Export-Import and JV-Investment since 2009.

These “Trade Fairs organized by MiTA” are the Great Market Platforms to initiate & grow Business in Myanmar. Supported by a PROMISE to help you find Medical Distributors & JV-Investment Partners, network with Myanmar Medical Companies, Myanmar Cosmetics Companies, Cosmetics Importers in Myanmar, Myanmar Pharma Importers, Hospitals, Doctors & Policy Makers; and know “how to do business in Myanmar”.

EU Ambassador, Harvard Business School (HBS) and Singapore International Arbitration Center (SIAC) will also present along with UMFCCI and Myanmar Government Ministry officials during YgTF 2017. MiTA Myanmar Exhibitions and Conferences which were held in 2015 & 2016 were grand success.

COSMETICS & BEAUTY EXPO IN MYANMAR, website: http://beauty-cosmetics-fashion.mitamyanmar.com/

SUPPORTING-ORGANIZATIONS:
– HARVARD BUSINESS SCHOOL
– SIAC-SINGAPORE
– Department for International Trade (UK), Myanmar Office
– A-MCC (Australia-Myanmar Chamber of Commerce)
– Mandalay Region Chamber of Commerce and Industry

BROCHURE-Download:
http://mitamyanmar.com/download/cosmetics-beauty-expo-in-myanmar-mhc-ygtf.pdf
– Price-List,
– MYANMAR CONFERENCE Agenda,
– Expo & Conference Hall-Layout,
– Expo-Booth-Facilities and
– Experience (Recommendation) in last Expo

PRICE till 6 January 2017

USD 3100 per 9 SQM (3mx3m) with standard booth-facilities

USD 500 per Conference Delegate with networking lunch & tea-coffee breaks

EXHIBIT PROFILES

1.1 MYANMAR COSMETICS EXPO

1.11 Cosmetics & Beauty Products
– Cosmetics, Skincare Products
– Antiaging, Beauty Enhancement
– Salon Cosmetics
– Organic & Herbal Beauty Products
– Make-up, Haircare
– Men’s Beauty Care, etc.

1.12 Tools & Equipment
– Tools
– Accessories & Packaging
– Salon and Spa Furniture & Tools
– Laser Treatment Equipment
– Cosmetics Manufacturing – Lab testing, etc.

1.2 MYANMAR LABORATORY EXPO

1.21 Laboratory Instruments
– Analytical & Lab Instruments
– Material & Water Testing Instruments
– Environmental Lab Instruments
– Testing & Measuring Instruments
– Diagnostics & Medical Instruments
– Lab Automation

1.22 Lab Products & Consumables
– Educational Lab Products for all levels
– Laboratory Animation and Software
– Biotechnology & Life Sciences
– Laboratory Planning
– Lab Glassware & Plastic-ware
– Environmental Science

1.3 MYANMAR PHARMACEUTICALS EXPO

1.31 Pharma & Food Supplement
– Pharmaceutical Products
– Bulk Drugs
– Generics & OTC
– Baby Foods
– Food Supplements
– Veterinary Drugs
– Additives

1.32 Pharma Equipment & Machineries
– Tableting
– Tube Filling
– Labelling
– Preparation Machinery
– Packing Machinery
– Liquid Filling Machinery

HOW TO JOIN THE CONFERENCE & EXPO IN MYANMAR?

Please email following information so that we can email you available booth-numbers and help you to do the online-registration:
– Your contact address and phone-number
– Your company's Contact person name, position, phone-number and email-address.
– Your full company name and address for invoicing purposes.
– How many exhibition-booths (each booth is 9 SQM) and conference delegate-tickets do you want to book?

Email: thazin@mitaservices.com.sg, mhc1@mita-myanmar.com
Phone: +95 9420 110 451, +95 9420 110 666

Dr. MADHAB PAUL, MANAGING DIRECTOR OF MiTA

www.madhabpaul.com

Dr. Madhab Paul, also speak about Opportunities in Myanmar in several international events. His recent speaking engagement was during "Russia & Asia Business Forum"; more info about the Forum: http://raibf.com/en/home-page/ . Dr. Paul traveled extensively in India, USA, Germany, China, Singapore, Vietnam, Philippine, Thailand and Myanmar, as well as, many other countries which he visited for business / work / pleasure for a short period. He did PhD in Civil (Geo-technical) Engineering and has post-graduate education in Law & Management; also did "Doing Business in Emerging Market" a short course from Harvard Business School (HBS). Please email to: isbc@mitaservices.com.sg if you wish to invite Dr. Madhab Paul to speak at your international conference / private investor's meeting.

ORGANIZER: MiTA

MiTA is Myanmar Market Partner for Export-Import and JV-Investment in Myanmar. MiTA Myanmar @ ISBC is preferred Partner for JV-Investment, Export-Import, Real Estate (www.mitaproperty.com) and Manufacturing since 2011. MiTA Services Pte Ltd (Singapore) is providing consulting for investment and trade in Myanmar since 2009. MiTA's one of the major initiatives now is making "Made-In-Myanmar" brand: www.1pya.com

Since 2014, to help you explore Myanmar Market, MiTA is organizing Myanmar Exhibitions, Myanmar Conferences and B-2-B Business Meetings. These events are the "Great Market Platforms" to initiate & grow Business in Myanmar. Supported by a PROMISE to help you find Distributors and JV-Investment Partners, trade Myanmar Market and get to know how to do business in Myanmar.

Think about "Doing Business in Myanmar" Beauty-Cosmetics-Pharma Sector, contact MiTA Myanmar; attend MiTA Myanmar Exhibition and Conference for Brand Promotion and Product Launch!

MiTA: MYANMAR MARKET PARTNER Since 2009

Welcome you all to MYANMAR, the land of new OPPORTUNITIES! www.digitalmarketing.ink

DOING BUSINESS IN MYANMAR: Quick-Links

Advantages in Myanmar: http://advantages-myanmar.com/

Myanmar-Trade-Investment News: http://myanmarbusinessnews.mitamyanmar.com/

Myanmar Trade Fair in Mandalay: http://mandalay-business.expo-mita.com/

Myanmar Investment Commission & MIC-Permit: http://myanmarinvestmentbusiness.com/myanmar-investment-commission-mic-permit-company-registration-dica-directorate-of-investment-and-company-administration/

Company Registration in Myanmar: https://mitaservices.com.sg/services/company-incorporation-in-myanmar/foreign-investment-mic-permit-dica-registration/

IEE-EIA-HIA-SIA-CSR in Myanmar: https://mitaservices.com.sg/services/eia-sia-csr-consulting/

Techno-Commercial Due-Diligence in Myanmar: https://mitaservices.com.sg/services/due-diligence-consulting/

JOBS-Recruitment in Myanmar: http://mitajobs.com/

Myanmar FDA Registration: http://myanmar-fda-registration.mitamyanmar.com/

Property Marketing in Myanmar: http://mitaproperty.com/

Myanmar Oil & Gas Expo: https://www.jetro.go.jp/j-messe/tradefair_en/MiTAMyanmar_54260

Myanmar Oil & Gas Exploration, Charter-Hire Offshore Vessels, Fabrication & Installation: https://mitaservices.com.sg/clients-projects-of-mita/

DIGITAL-MARKETING & GLOBAL-BRANDING: www.digitalmarketing.ink

JETRO JAPAN – Myanmar Expo News
Myanmar Cosmetics, Beauty, Spa & Wellness Products Expo: https://www.jetro.go.jp/j-messe/tradefair_en/spaCOSMO_53989
Myanmar Healthcare: https://www.jetro.go.jp/j-messe/tradefair_en/MHCMYANMAR_53983
Myanmar Pharmaceutical: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarPharma_53984
Myanmar Medical Laboratory Expo: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarLab_54254
Myanmar Sports & Fitness: https://www.jetro.go.jp/j-messe/tradefair_en/MyanmarPhysiotherapy_53985

Myanmar Beauty & Cosmetics Expo @ YgTF 2017, February 24-26 and June 23-25:
We invite your participation in case you are interested in "Doing Business in Myanmar" or exploring Beauty-Cosmetics Market in Myanmar.

MiTA DIGITAL MARKETING INK http://digitalmarketing.ink
MiTA Services Pte Ltd
00959420110451
email us here


Source: EIN Presswire

Facebook presents mobile solutions for patient engagement and personalised marketing

The 9th Social Media in the Pharmaceutical Industry event will take place in January 2017

Sachin Nanavati, Facebook Health

Facebook to explore

One key shift is how rapidly people have moved to mobile. And in part thanks to this shift, we've seen people increasingly leverage platforms like Facebook as a central place for health-conversation.

— Sachin Nanavati, Facebook Health

LONDON, ENGLAND, UNITED KINGDOM, November 28, 2016 /EINPresswire.com/ — Sachin Nanavati, Manager of Global Marketing Solutions at social media giant Facebook, joins the expert speaker line-up for the 9th Social Media in the Pharmaceutical Industry which takes place on the 18th and 19th of January 2017 in London.

With a focus on leveraging the Facebook platform to achieve personalised marketing at scale, Sachin’s keynote presentation will explore the advantages of using Facebook as a central place for evidence-based healthcare discussions through full-funnel marketing so as to reach and engage the right patients with the right message at the right time. He will also discuss creative best practices for branded and unbranded campaigns.

In a recent interview with SMi Group, Sachin talked about how shifts in consumer behaviour have brought forth an avenue for patients and HCPs to engage more on Facebook.

“One key shift is how rapidly people have moved to mobile. And in part thanks to this shift, we've seen people increasingly leverage platforms like Facebook as a central place for health-conversation. In fact, there are 6 million health related-groups on Facebook with over 70 million members. This level of health engagement presents a massive opportunity for healthcare brands to contextualize the right message to the right patient at the right time on Facebook – particularly on mobile. It's a content discovery platform where nearly 1.8 billion people come to engage with the people and brands that matter most to them in their lives.

It's really exciting to think about this from a patient perspective and the possibility that a more open and connected world has to improve health outcomes. Facebook is a safe and powerful way for marketers to engage patients at scale with contextualized evidence-based messages to help them make the best decisions for their health. It’s also powerful channel for vibrant patient communities where people can safely connect, share and meet other people like them. Patient communities like ActuallySheCan and SaveYourBreath are great examples of brands building meaningful platforms on Facebook that go beyond the pill.”

The full interview with Sachin is available to view at the Download Centre on www.social-media-pharma.com/EIN.

Sachin joins an line-up of expert healthcare practitioners and marketers who will discuss and debate the latest trends in e-healthcare, technologies, and top tricks of the trade to maximise digital strategy. Other speakers include CREATION, Lundbeck, MHRA, Merck, Pfizer, GE Healthcare Life Sciences, AbbVie, Leo Pharma, and more

For more updates on the conference, follow SMi Group on @smipharm and join the conversation using #pharmasocialmedia on Twitter.

9th Social Media in the Pharmaceutical Industry
18 & 19 January 2017
Holiday Inn Kensington Forum, London, UK
http://www.social-media-pharma.com/EIN

—end —

Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Matthew Apps at mapps@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Honey de Gracia
SMi Group Ltd
+44 (0)20 7827 6102
email us here


Source: EIN Presswire

Pure Type 2 Collagen Has Proven To Be The "Anti-Aging" Miracle Of The Day Helping To Eliminate Wrinkles

Secret Shoppers Society, inc. A Beverly Hills, Ca. Corporation Is Licensed To Distribute Pure Type 2 Collagen In Capsule Form!

Do You Want To Reduce Fine Lines & Wrinkles While Relieving Yourself From Joint Aches and Pains?

— Ronald L. Calvin

BEVERLY HILLS, CA, UNITED STATES, November 27, 2016 /EINPresswire.com/ — As Many People Already Know, Collagen Creams Can Help Reduce Fine Lines and Wrinkles and Have Enjoyed A Certain Amount Of Attention Over The Past Few Years. Actually The Collagen Creams That Are Around Only Have A Relatively Small Amount Of Collagen In Them and Are Not Pure Type 2 Collagen, So The Results Are Usually Quite Temporary and Limited. Pure Type 2 Collagen Took Things To The Next Level and Proved To Be The "Anti-Aging" Miracle Of The Day, If Consumers Could Stand Getting Needles and Injections Directly Into Their Face. That Was The Limiting Factor Because In The Past People Could Only Benefit From It If It Was Injected. But Now All Of That Is Changed, Because Now It Is Available In Capsule Form. Consumers Can Now Say Goodbye To Surgery! Now Anyone Can Literally Have A Face-Lift In A Jar! And There Are So Many More Benefits That It Gets Even Better…In Recent Studies Pure Collagen Can Drastically Relieve Joint Pain! Early Users Have Said That While Taking The Collagen Their Joint Pain Symptoms Had Considerably Been Reduced After Just A Few Months Of Daily Use. It's Accomplished This By replacing The Lack Of Cartilage That Leads To Joint Pain. Joint Pain Suffers Are Reaching Epidemic Levels and Joint Pain Is Not Curable By Any Means. However, Taking Pure Type 2 Collagen Can Give Almost Anyone Dramatic Relief. Results Vary From Individuals Depending On The Severity Of The Case. There Are Plenty Of Collagen Products Available If Consumers Look For Them, But They Are Not Pure Type 2 Collagen and Simply Do Not Compare! Encore Collagen Is Pure Type 2 Collagen and Must Be Tried To Believe The Results That People Are Getting. Collagen Is The Body's Most Abundant Natural Protein. It Is The "Glue" That Holds The Body Together and Is The Essential Structural Component Of All Connective Tissue. 75% Of Skin Is Collagen! The Use Of Collagen To Aid A Range Of Disorders Has Been Well Documented and Dates All The Way Back To The Twelfth Century. Joint Pain Is Characterized By The Gradual But Progressive Damage To The Joints. Present Day Treatment Is Based Mainly On Physical Therapy Including Heat, Massage and Movement and Sometimes, Steroids and Pain Killers. The Main Reason This Doesn't Work Well Is Because It Fails To Tackle The Heart Of The Problem. Encore Collagen Is A Natural Food Supplement Designed By Some Of The Brightest Scientific Minds In The World. Wrinkles Are A Sure Indicator Of Collagen Deficiency. With Aging The Body Produces Less Collagen and Is Not Contained In Any Food Like Certain Vitamins Are. Visit Us Today at WWW.SECRETSHOPPERSSOCIETY.NET

Ronald L. Calvin
Secret Shoppers Society, inc.
310-464-0866
email us here


Source: EIN Presswire